Company intelligence / Profile preview

EVŌQ MedTech

Salt Lake City, Utah, United States

Ownership: Private
Development stage: Other

Overview

EVŌQ Nano develops non-ionic silver nanoparticles (EVQ-218) using a proprietary laser nanofabrication process. These nanoparticles demonstrate strong antimicrobial efficacy across medical devices, therapeutics, and textiles, with >4-log (99.99%) reduction against leading pathogens implicated in healthcare-associated infections. The company is advancing an inhaled therapeutic for pulmonary infections in cystic fibrosis through a partnership with the Cystic Fibrosis Foundation and recently completed a pre-IND meeting with the FDA[3][5][7].

Therapeutic areas: Infectious Diseases
Modalities: NanoparticleDevice
Industry: Biotech

Partnerships

Cystic Fibrosis Foundation (therapeutic development)Leading catheter manufacturers (medical device applications)Brand partners via FUZE Technologies (e.g., Nike, Adidas, Marriott, Hilton)

Beyond the preview

Go deeper on EVŌQ MedTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EVŌQ MedTech.

Explore the full profile